E-mail: bd@sidmexinovia.com
Telefone: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Erypeg 75 mcg PFS
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$83.22 $57.23
Erypeg 75 mcg is a pegylated erythropoietin injection designed to combat anemia, particularly in patients suffering from chronic kidney disease or those undergoing chemotherapy. As an erythropoiesis-stimulating agent (ESA), Erypeg...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Erythropoietin 75 mcg(Pegylated)
Active Pharmaceutical Ingredient
Erypeg 75 mcg PFS
US$ 83,22
US$ 57,23
Erypeg 75 mcg is a pegylated erythropoietin injection designed to combat anemia, particularly in patients suffering from chronic kidney disease or those undergoing chemotherapy. As an erythropoiesis-stimulating agent (ESA), Erypeg works by enhancing the bone marrow's ability to produce red blood cells, thereby helping to restore healthy hemoglobin levels. This medication is crucial for improving energy levels and overall quality of life in affected individuals. It’s important to monitor patients for potential side effects, such as high blood pressure or allergic reactions, and to follow dosing guidelines closely to ensure safety and efficacy. Always consult with a healthcare professional before starting Erypeg to discuss any existing medical conditions or medications that may interact with treatment. By supporting red blood cell production, Erypeg 75 mcg plays a vital role in managing anemia, making it a valuable option for those in need. Embrace the benefits of Erypeg as part of your comprehensive anemia treatment plan.
Active Pharmaceutical Ingredient
Usos
• Erypeg 75 mcg pfs is primarily indicated for the treatment of symptomatic anemia linked to chronic renal failure (CRF). This condition often arises when the kidneys are unable to produce sufficient erythropoietin, leading to reduced red blood cell production. By administering Erypeg 75 mcg pfs, patients can experience an improvement in hemoglobin levels. This is crucial for enhancing overall energy and reducing fatigue.
• Both adults and pediatric patients suffering from CRF can benefit from Erypeg 75 mcg pfs. It is effective for individuals on dialysis, who may have a higher risk of developing anemia due to their treatment regimen. Additionally, those not undergoing dialysis can also receive this medication to manage their anemia symptoms effectively. The use of Erypeg 75 mcg pfs helps restore the balance of red blood cells, contributing to better health outcomes.
• In clinical practice, Erypeg 75 mcg pfs is often utilized in various treatment settings to alleviate the burden of anemia in CRF patients. Healthcare providers may prescribe this medication to improve the quality of life for patients experiencing fatigue and weakness due to low hemoglobin levels. Regular administration of Erypeg 75 mcg pfs can lead to significant improvements in patients' daily activities and overall well-being. This makes it a vital part of the management plan for those affected by this condition.
• Erypeg 75 mcg pfs serves as an important therapeutic option for addressing anemia in patients with chronic renal failure. The medication works by stimulating the production of red blood cells, which is essential for maintaining adequate oxygen delivery throughout the body. Its application is particularly beneficial for managing anemia in both dialysis-dependent and non-dialysis-dependent patients. By incorporating Erypeg 75 mcg pfs into their treatment regimen, patients can achieve better control of their anemia symptoms.
Benefícios
Treatment of Anemia due to chronic kidney disease: Erypeg Injection is a man-made protein that helps your bone marrow make more red blood cells. It is used to treat anaemia caused by kidney disease in adults and children on dialysis. Anaemia is a condition in which your body does not have enough red blood cells to carry oxygen around your body. This medicine helps to reduce the weakness and tiredness you may feel due to anaemia. It is usually given by a doctor after dialysis treatment.
Treatment of anaemia caused by cancer chemotherapy: Anemia is a condition in which your body does not have enough red blood cells to carry oxygen around your body. Erythropoietin Pegylated Injection 75 mcg is a man-made protein that stimulates the bone marrow (soft tissue inside the bones) to produce more red blood cells. The natural human form of this protein may be reduced when you have chemotherapy to treat some types of cancer. An injection of the medicine may reduce the need for a blood transfusion. You may also be given an iron supplement to help make sure the treatment is more effective.
Efeitos colaterais
Like all medications, Erythropoietin Pegylated Injection 75 mcg can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor on the occasion that they persist or if you’re worried about them.
Efeitos colaterais mais comuns
• Feeling Sick
• Diarrhoea
• Headaches
• Vomiting
• Rash
• Hives
• Itching
• Tiredness
• Lack of energy
• Wheezing
• Skin blisters or peeling skin
• Dizziness
• Faining
• Swollen hands or feet
Efeitos colaterais comuns
• Chest Pain
• Difficulty breathing
• Swelling on the throat, lips, face, eyes or lips
• Breathlessness
• Eyesight problems
• Numbness or weakness in one side of your body
Como usar
Erythropoietin Pegylated Injection 75 mcg is available in liquid form and is administered subcutaneously by a slow injection. This Erypeg Injection is usually given in the abdomen or thigh. The dosage and frequency of injections for Erypeg 75 mcg will be determined by your healthcare provider. If you experience any serious side effects, it is important to tell your healthcare provider or doctor.
Conselhos de segurança
• Alcohol: It is generally not recommended to drink alcohol while taking Erythropoietin Pegylated Injection 75 mcg. It may also increase the chance of liver damage. it is far excellent to keep away from alcohol or restrict your alcohol intake while taking any medication.
• Kidney: Erypeg 75 mcg is safe to use in patients with kidney disease. No dose adjustment of Erypeg 75 mcg is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Erypeg 75 mcg. Erypeg 75 mcg may pass into breast milk and harm the infant. If you are breastfeeding and taking Erypeg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your health practitioner can be capin a position that will help you make the nice choice for you and your baby's health.
• Liver: Erythropoietin Pegylated Injection 75 mcg should be used with caution in patients with liver disease. Sufferers with liver disease must monitor their liver closely even while taking Erypeg 75 mcg and report any unusual symptoms or changes in liver function to their doctor. The dose of Erypeg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Animal studies suggest that Erythropoietin Pegylated Injection 75 mcg may harm the developing foetus, so it may not be safe to use Erypeg 75 mcg during pregnancy. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erypeg 75 mcg while pregnant. Your doctor will be able to help you make the best decision for you and the health of your baby.
• Driving: This Erypeg 75 mcg may cause dizziness, drowsiness, and problems with concentration and coordination, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's orders and take important precautions, including not driving or operating heavy machinery, if you are experiencing the side effects of this Erythropoietin Pegylated Injection 75 mcg.
Isenção de responsabilidade
A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.
Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.
Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.
Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.